|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/22 | |
| A61K 9/52 | |||
| A61K 45/06 | |||
| A61K 31/422 | |||
| A61K 31/454 | |||
| A61K 31/4545 | |||
| A61K 31/496 | |||
| A61K 31/505 | |||
| A61P 25/14 | |||
| A61P 25/16 | |||
| A61K 9/28 |
| (11) | Number of the document | 2838517 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13725557.6 |
| Date of filing the European patent application | 2013-04-18 | |
| (97) | Date of publication of the European application | 2015-02-25 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/DK2013/050111 |
| Date | 2013-04-18 |
| (87) | Number | WO 2013/156035 |
| Date | 2013-10-24 |
| (30) | Number | Date | Country code |
| 201270196 | 2012-04-18 | DK | |
| PCT/DK2012/0501 | 2012-06-01 | WO | |
| 201270755 | 2012-12-04 | DK |
| (72) |
HANSEN, John Bondo, DK
THOMSEN, Mikael S., DK
MIKKELSEN, Jens D., DK
NIELSEN, Peter Gudmund, DK
KREILGAARD, Mads, DK
|
| (73) |
Contera Pharma APS,
Ole Maal es Vej 3, 2200 Copenhagen N,
DK
|
| (54) | ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS |
| ORALLY AVAILABLE PHARMACEUTICAL FORMULATION SUITABLE FOR IMPROVED MANAGEMENT OF MOVEMENT DISORDERS |